Working Principle of Protease Inhibitors in In Vitro Diagnostics

The working principle of in vitro diagnostic protease inhibitors mainly involves regulating protease activity to affect protein degradation in biological samples. Proteases are a class of soluble enzyme proteins found both inside and outside cells, capable of hydrolyzing proteins. In in vitro diagnostics, when control over the protein hydrolysis process is needed, protease inhibitors can be added to intervene in this process.
In vitro diagnostic protease inhibitors can act on proteases through various mechanisms. For example, inhibitors can bind to proteases to form irreversible complexes, thereby inhibiting enzyme activity. Additionally, some inhibitors can competitively bind to the active site of proteases, blocking their interaction with substrates and thus inhibiting their activity.
By using in vitro diagnostic protease inhibitors, laboratories can precisely control and monitor the protein hydrolysis process in samples, aiding in the study of protein structure and function. At the same time, these inhibitors also play an important role in clinical diagnostics, helping doctors and researchers obtain accurate experimental data.
In summary, in vitro diagnostic protease inhibitors control the protein hydrolysis process in biological samples by affecting protease activity, thereby playing an important role in laboratory diagnostics and research.